Published in Am Nat on October 01, 2009
Dengue vector control strategies in an urban setting: an economic modelling assessment. Lancet (2011) 2.24
West Nile Virus: biology, transmission, and human infection. Clin Microbiol Rev (2012) 1.38
Male mating history and body size influence female fecundity and longevity of the dengue vector Aedes aegypti. J Med Entomol (2011) 1.05
Modeling transmission dynamics and control of vector-borne neglected tropical diseases. PLoS Negl Trop Dis (2010) 1.02
Wolbachia versus dengue: Evolutionary forecasts. Evol Med Public Health (2013) 0.95
Braess's paradox in epidemic game: better condition results in less payoff. Sci Rep (2013) 0.86
Influence of vectors' risk-spreading strategies and environmental stochasticity on the epidemiology and evolution of vector-borne diseases: the example of Chagas' disease. PLoS One (2013) 0.86
Feasible introgression of an anti-pathogen transgene into an urban mosquito population without using gene-drive. PLoS Negl Trop Dis (2014) 0.83
A protocol for collecting and staining hemocytes from the yellow fever mosquito Aedes aegypti. J Vis Exp (2011) 0.83
Release of genetically engineered insects: a framework to identify potential ecological effects. Ecol Evol (2013) 0.83
When does pathogen evolution maximize the basic reproductive number in well-mixed host-pathogen systems? J Math Biol (2012) 0.79
Can Horton hear the whos? The importance of scale in mosquito-borne disease. J Med Entomol (2014) 0.77
Cost-effectiveness of dengue vaccination in Yucatán, Mexico using a dynamic dengue transmission model. PLoS One (2017) 0.75
Dengue and dengue hemorrhagic fever. Clin Microbiol Rev (1998) 19.59
Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis (2000) 11.44
Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission. Math Biosci (2002) 11.13
Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol (2002) 10.92
Dengue: an update. Lancet Infect Dis (2002) 9.02
Research on dengue during World War II. Am J Trop Med Hyg (1952) 8.76
Models of parasite virulence. Q Rev Biol (1996) 8.53
Coevolution of hosts and parasites. Parasitology (1982) 7.55
Insecticide resistance in insect vectors of human disease. Annu Rev Entomol (2000) 6.66
Global spread and persistence of dengue. Annu Rev Microbiol (2008) 6.44
Stable introduction of a life-shortening Wolbachia infection into the mosquito Aedes aegypti. Science (2009) 6.41
Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology (1997) 4.88
Imperfect vaccines and the evolution of pathogen virulence. Nature (2001) 4.74
Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J Infect Dis (2002) 4.67
Superinfection and the evolution of parasite virulence. Proc Biol Sci (1994) 4.57
Epidemiology and genetics in the coevolution of parasites and hosts. Proc R Soc Lond B Biol Sci (1983) 4.52
Insect population control using a dominant, repressible, lethal genetic system. Science (2000) 4.41
The ecology of genetically diverse infections. Science (2001) 4.37
Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. Yale J Biol Med (1970) 4.30
Emergence and global spread of a dengue serotype 3, subtype III virus. Emerg Infect Dis (2003) 4.29
Dengue virus structural differences that correlate with pathogenesis. J Virol (1999) 4.26
Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever. Lancet (1999) 3.97
The origin, emergence and evolutionary genetics of dengue virus. Infect Genet Evol (2003) 3.83
Gene drive systems for insect disease vectors. Nat Rev Genet (2006) 3.81
Engineering RNA interference-based resistance to dengue virus type 2 in genetically modified Aedes aegypti. Proc Natl Acad Sci U S A (2006) 3.62
Spatial and temporal clustering of dengue virus transmission in Thai villages. PLoS Med (2008) 3.59
Microevolution and virulence of dengue viruses. Adv Virus Res (2003) 3.41
Epidemiologic, clinical, and virologic observations on dengue in the Kingdom of Tonga. Am J Trop Med Hyg (1978) 3.08
Viraemia in patients with naturally acquired dengue infection. Bull World Health Organ (1981) 2.99
Ecological and immunological determinants of dengue epidemics. Proc Natl Acad Sci U S A (2006) 2.92
Virulence and transmissibility of pathogens: what is the relationship? Trends Microbiol (1997) 2.91
Genetically engineered resistance to dengue-2 virus transmission in mosquitoes. Science (1996) 2.90
The evolution of virulence in parasites and pathogens: reconciliation between two competing hypotheses. J Theor Biol (1994) 2.67
Coinfection and the evolution of parasite virulence. Proc Biol Sci (1995) 2.59
Selection for virulent dengue viruses occurs in humans and mosquitoes. J Virol (2005) 2.50
A kin selection model for the evolution of virulence. Proc Biol Sci (1992) 2.27
Differential susceptibility of Aedes aegypti to infection by the American and Southeast Asian genotypes of dengue type 2 virus. Vector Borne Zoonotic Dis (2001) 2.20
Efficiency of dengue serotype 2 virus strains to infect and disseminate in Aedes aegypti. Am J Trop Med Hyg (2003) 2.16
The ecology of genetically modified mosquitoes. Science (2002) 2.09
Analysis of repeat hospital admissions for dengue to estimate the frequency of third or fourth dengue infections resulting in admissions and dengue hemorrhagic fever, and serotype sequences. Am J Trop Med Hyg (2007) 2.06
Virulence in malaria: an evolutionary viewpoint. Philos Trans R Soc Lond B Biol Sci (2004) 2.04
Dynamic effects of antibody-dependent enhancement on the fitness of viruses. Proc Natl Acad Sci U S A (2005) 2.02
A competitive exclusion principle for pathogen virulence. J Math Biol (1989) 2.01
Possible use of translocations to fix desirable genes in insect pest populations. Nature (1968) 1.99
Impact of dengue virus infection on feeding behavior of Aedes aegypti. Am J Trop Med Hyg (1997) 1.90
Community involvement in the control of Aedes aegypti. Acta Trop (1996) 1.88
Ecological interference between fatal diseases. Nature (2003) 1.87
Superinfection, metapopulation dynamics, and the evolution of diversity. J Theor Biol (1994) 1.68
Dominant lethality and insect population control. Mol Biochem Parasitol (2002) 1.64
Monitoring of dengue viruses in field-caught Aedes aegypti and Aedes albopictus mosquitoes by a type-specific polymerase chain reaction and cycle sequencing. Am J Trop Med Hyg (1998) 1.55
Sindbis virus-induced silencing of dengue viruses in mosquitoes. Insect Mol Biol (2001) 1.55
Engineering blood meal-activated systemic immunity in the yellow fever mosquito, Aedes aegypti. Proc Natl Acad Sci U S A (2000) 1.53
Uncertainties regarding dengue modeling in Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz (2003) 1.51
Evolution of multihost parasites. Evolution (2004) 1.47
Densoviruses for control and genetic manipulation of mosquitoes. Adv Virus Res (2006) 1.44
Optimal growth schedule of pathogens within a host: switching between lytic and latent cycles. Theor Popul Biol (1991) 1.38
Evolution of parasite virulence when host responses cause disease. Proc Biol Sci (2007) 1.26
Entomological investigations in a focus of dengue transmission in Cairns, Queensland, Australia, by using the sticky ovitraps. J Med Entomol (2004) 1.24
Why are dengue virus serotypes so distantly related? Enhancement and limiting serotype similarity between dengue virus strains. Proc Biol Sci (2003) 1.23
Growth of dengue type 2 virus isolates in human peripheral blood leukocytes correlates with severe and mild dengue disease. Am J Trop Med Hyg (1991) 1.13
Persistent emergence of dengue. Emerg Infect Dis (2005) 1.11
Infection and pathogenicity of the mosquito densoviruses AeDNV, HeDNV, and APeDNV in Aedes aegypti mosquitoes (Diptera: Culicidae). J Econ Entomol (2004) 1.10
Questions on viral population biology to complete dengue puzzle. Trends Microbiol (2003) 1.04
Developing arbovirus resistance in mosquitoes. Insect Biochem Mol Biol (2002) 1.04
Microbiology. Mosquitoes cut short. Science (2009) 0.98
Characterization of the AeaHP gene and its expression in the mosquito Aedes aegypti (Diptera: Culicidae). J Med Entomol (2002) 0.97
Evolution of dengue virus type 2 during two consecutive outbreaks with an increase in severity in southern Taiwan in 2001-2002. Am J Trop Med Hyg (2008) 0.89
A mosquito densovirus infecting Aedes aegypti and Aedes albopictus from Thailand. Am J Trop Med Hyg (1999) 0.86
Ecological and immunological determinants of influenza evolution. Nature (2003) 7.60
Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis. Lancet Infect Dis (2009) 6.81
Optimizing influenza vaccine distribution. Science (2009) 4.37
Effect of Ebola progression on transmission and control in Liberia. Ann Intern Med (2014) 3.96
Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study. Lancet (2007) 3.65
Genome sequences of the human body louse and its primary endosymbiont provide insights into the permanent parasitic lifestyle. Proc Natl Acad Sci U S A (2010) 2.76
Epidemiology: dimensions of superspreading. Nature (2005) 2.47
Group interest versus self-interest in smallpox vaccination policy. Proc Natl Acad Sci U S A (2003) 2.45
Dengue vector control strategies in an urban setting: an economic modelling assessment. Lancet (2011) 2.24
Time series analysis of dengue incidence in Rio de Janeiro, Brazil. Am J Trop Med Hyg (2008) 2.05
Curtailing transmission of severe acute respiratory syndrome within a community and its hospital. Proc Biol Sci (2003) 2.02
Evolving public perceptions and stability in vaccine uptake. Math Biosci (2006) 1.96
Averting epidemics of extensively drug-resistant tuberculosis. Proc Natl Acad Sci U S A (2009) 1.76
Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future. Epidemiology (2005) 1.75
Cost-effectiveness of genotype testing for primary resistance in Brazil. J Acquir Immune Defic Syndr (2015) 1.73
Cost-effectiveness of canine vaccination to prevent human rabies in rural Tanzania. Ann Intern Med (2014) 1.73
Epidemiology. Social factors in epidemiology. Science (2013) 1.71
Effects of Response to 2014-2015 Ebola Outbreak on Deaths from Malaria, HIV/AIDS, and Tuberculosis, West Africa. Emerg Infect Dis (2016) 1.70
Adherence to cervical screening in the era of human papillomavirus vaccination: how low is too low? Lancet Infect Dis (2010) 1.65
Ebola vaccination: if not now, when? Ann Intern Med (2014) 1.57
The geographic spread of the CCR5 Delta32 HIV-resistance allele. PLoS Biol (2005) 1.46
Changing mortality profile among HIV-infected patients in Rio de Janeiro, Brazil: shifting from AIDS to non-AIDS related conditions in the HAART era. PLoS One (2013) 1.46
Early mortality and cause of deaths in patients using HAART in Brazil and the United States. AIDS (2009) 1.32
Sepsis is a major determinant of outcome in critically ill HIV/AIDS patients. Crit Care (2010) 1.30
Evaluating the cost-effectiveness of rabies post-exposure prophylaxis: a case study in Tanzania. Vaccine (2009) 1.28
Self-reported skin color, genomic ancestry and the distribution of GST polymorphisms. Pharmacogenet Genomics (2007) 1.28
Vector host-feeding preferences drive transmission of multi-host pathogens: West Nile virus as a model system. Proc Biol Sci (2011) 1.24
A general approach for population games with application to vaccination. Math Biosci (2011) 1.24
Integrating epidemiology, psychology, and economics to achieve HPV vaccination targets. Proc Natl Acad Sci U S A (2008) 1.22
The dynamics of risk perceptions and precautionary behavior in response to 2009 (H1N1) pandemic influenza. BMC Infect Dis (2010) 1.20
Dengue infection increases the locomotor activity of Aedes aegypti females. PLoS One (2011) 1.16
Potential for rabies control through dog vaccination in wildlife-abundant communities of Tanzania. PLoS Negl Trop Dis (2012) 1.10
Vaccination against multiple HPV types. Math Biosci (2005) 1.09
Infections with immunogenic trypanosomes reduce tsetse reproductive fitness: potential impact of different parasite strains on vector population structure. PLoS Negl Trop Dis (2008) 1.09
How host heterogeneity governs tuberculosis reinfection? Proc Biol Sci (2012) 1.08
The impact of imitation on vaccination behavior in social contact networks. PLoS Comput Biol (2012) 1.07
Erratic flu vaccination emerges from short-sighted behavior in contact networks. PLoS Comput Biol (2011) 1.07
The influence of altruism on influenza vaccination decisions. J R Soc Interface (2012) 1.07
The effect of treatment on pathogen virulence. J Theor Biol (2004) 1.06
Immune status at presentation for HIV clinical care in Rio de Janeiro and Baltimore. J Acquir Immune Defic Syndr (2011) 1.04
Genomic rearrangements and transcriptional analysis of the spliced leader-associated retrotransposon in RNA interference-deficient Trypanosoma brucei. Mol Microbiol (2007) 1.04
Evaluating candidate agents of selective pressure for cystic fibrosis. J R Soc Interface (2007) 1.04
The ethics of influenza vaccination. Science (2006) 1.04
Impact of transmission dynamics on the cost-effectiveness of rotavirus vaccination. Vaccine (2009) 1.04
Vaccinating in disease-free regions: a vaccine model with application to yellow fever. J R Soc Interface (2007) 1.03
Vaccinating to help ourselves and others. Med Decis Making (2011) 1.03
Modeling transmission dynamics and control of vector-borne neglected tropical diseases. PLoS Negl Trop Dis (2010) 1.02
Epidemiological game-theory dynamics of chickenpox vaccination in the USA and Israel. J R Soc Interface (2011) 1.01
Glossina fuscipes populations provide insights for human African trypanosomiasis transmission in Uganda. Trends Parasitol (2013) 1.01
Incidence of modifying or discontinuing first HAART regimen and its determinants in a cohort of HIV-infected patients from Rio de Janeiro, Brazil. AIDS Res Hum Retroviruses (2010) 1.01
When does overuse of antibiotics become a tragedy of the commons? PLoS One (2012) 0.99
Associations between defined polymorphic variants in the PfRH ligand family and the invasion pathways used by P. falciparum field isolates from Brazil. Mol Biochem Parasitol (2006) 0.98
Optimal timing of disease transmission in an age-structured population. Bull Math Biol (2007) 0.98
The cost-effectiveness of pentavalent rotavirus vaccination in England and Wales. Vaccine (2012) 0.97
Seroprevalence and factors associated with herpes simplex virus type 2 among HIV-negative high-risk men who have sex with men from Rio de Janeiro, Brazil: a cross-sectional study. BMC Infect Dis (2009) 0.96
Impact of rotavirus vaccination on epidemiological dynamics in England and Wales. Vaccine (2011) 0.96
Using game theory to examine incentives in influenza vaccination behavior. Psychol Sci (2012) 0.94
In vitro-reduced susceptibility to artemether in P. falciparum and its association with polymorphisms on transporter genes. J Infect Dis (2012) 0.94
Pharmacogenomic implications of population admixture: Brazil as a model case. Pharmacogenomics (2014) 0.93
The theoretical influence of immunity between strain groups on the progression of drug-resistant tuberculosis epidemics. J Infect Dis (2008) 0.93
Viral load and CD4 count dynamics after HIV-1 seroconversion in homosexual and bisexual men in Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr (2006) 0.92
Improved virologic outcomes over time for HIV-infected patients on antiretroviral therapy in a cohort from Rio de Janeiro, 1997-2011. BMC Infect Dis (2014) 0.92
Evolutionary repercussions of avian culling on host resistance and influenza virulence. PLoS One (2009) 0.92
Reevaluation of epidemiological data demonstrates that it is consistent with cross-immunity among human papillomavirus types. J Infect Dis (2012) 0.91
Distinguishing vaccine efficacy and effectiveness. Vaccine (2012) 0.91
Anal human papillomavirus (HPV) prevalences and factors associated with abnormal anal cytology in HIV-infected women in an urban cohort from Rio de Janeiro, Brazil. AIDS Patient Care STDS (2015) 0.90
Decision making with regard to antiviral intervention during an influenza pandemic. Med Decis Making (2010) 0.90
Pharmacogenetics of calcineurin inhibitors in Brazilian renal transplant patients. Pharmacogenomics (2011) 0.90
Dengue dynamics and vaccine cost-effectiveness in Brazil. Vaccine (2013) 0.89
Evaluating paratransgenesis as a potential control strategy for African trypanosomiasis. PLoS Negl Trop Dis (2013) 0.88
Direct and indirect effects of rotavirus vaccination: comparing predictions from transmission dynamic models. PLoS One (2012) 0.87
The epidemiological impact of HIV antiretroviral therapy on malaria in children. AIDS (2015) 0.87
Optimal H1N1 vaccination strategies based on self-interest versus group interest. BMC Public Health (2011) 0.87
Interrupting Ebola Transmission in Liberia Through Community-Based Initiatives. Ann Intern Med (2016) 0.86
Relative contribution of VKORC1, CYP2C9, and INR response to warfarin stable dose. Blood (2009) 0.86
Cost-effectiveness of a community-based intervention for reducing the transmission of Schistosoma haematobium and HIV in Africa. Proc Natl Acad Sci U S A (2013) 0.85
Time for change? An economic evaluation of integrated cervical screening and HPV immunization programs in Canada. Vaccine (2011) 0.85
Potential cost-effectiveness of schistosomiasis treatment for reducing HIV transmission in Africa--the case of Zimbabwean women. PLoS Negl Trop Dis (2013) 0.84
The evolution of tuberculosis virulence. Bull Math Biol (2009) 0.84
Extensively drug-resistant tuberculosis in South Africa. Lancet (2007) 0.84
Optimal targeting of seasonal influenza vaccination toward younger ages is robust to parameter uncertainty. Vaccine (2013) 0.83
Preferences for HPV vaccination in parent-child dyads: Similarities and acknowledged differences. Prev Med (2011) 0.83
Incidence and determinants of severe morbidity among HIV-infected patients from Rio de Janeiro, Brazil, 2000-2010. Antivir Ther (2014) 0.83
A Comparison of Seven Cox Regression-Based Models to Account for Heterogeneity Across Multiple HIV Treatment Cohorts in Latin America and the Caribbean. AIDS Res Hum Retroviruses (2015) 0.83
Vaccination and the evolutionary ecology of human papillomavirus. Vaccine (2008) 0.83
Random-effects models in investigating the effect of vitamin A in childhood diarrhea. Ann Epidemiol (2005) 0.83
Cost-Effectiveness of Pertussis Vaccination During Pregnancy in the United States. Am J Epidemiol (2016) 0.83
Re: "Multiparameter calibration of a natural history model of cervical cancer". Am J Epidemiol (2007) 0.83
Predicted outcomes of vaccinating wildlife to reduce human risk of Lyme disease. Vector Borne Zoonotic Dis (2012) 0.82
Modeling targeted ivermectin treatment for controlling river blindness. Am J Trop Med Hyg (2006) 0.81
Controlling antimicrobial resistance through targeted, vaccine-induced replacement of strains. PLoS One (2012) 0.79
H1N1pdm09 adjuvanted vaccination in HIV-infected adults: a randomized trial of two single versus two double doses. PLoS One (2012) 0.79
Impact of program scale and indirect effects on the cost-effectiveness of vaccination programs. Med Decis Making (2012) 0.79
A negative correlation between dengue and bushfires in Brazil. J Environ Health (2014) 0.79
How do people value life? Psychol Sci (2009) 0.79